| Issue |
Section |
Title |
File |
| Vol 17, No 1 (2015) |
Articles |
Arterial hypertension and cognitive function |
(Rus)
|
| Vol 17, No 1 (2015) |
Articles |
Approaches to the choice of a statin to treat patients on an outpatient basis |
(Rus)
|
| Vol 17, No 5 (2015) |
Articles |
Circadian rhythm of blood pressure: prognostic significance and possibility to correct it during the treatment using azilsartan medoxomil |
(Rus)
|
| Vol 17, No 10 (2015) |
Articles |
Combined therapy in hypertension: a new fixed-dose combination of angiotensin II receptor blockers and diuretics (azilsartan medoxomil and chlorthalidone) |
(Rus)
|
| Vol 18, No 1 (2016) |
Articles |
Angiotensin-converting enzyme inhibitors - the risk of dementia and possibilities of improving cognitive functions:the unique characteristics of perindopril |
(Rus)
|
| Vol 17, No 10 (2015) |
Articles |
Prevention of stroke and dementia in high-risk patients |
(Rus)
|
| Vol 18, No 5 (2016) |
Articles |
Dihydropyridine calcium channel blockers in the treatment of arterial hypertension: efficacy and safety of felodipine |
(Rus)
|
| Vol 19, No 2-3 (2017) |
Articles |
Blood pressure indices and sleep quality in elderly patients with chronic cerebral ischemia and arterial hypertension on the background of treatment with Pantocalcin (gopanthenic acid). The results of the PLATON noninterventional observational program |
(Rus)
|
| Vol 19, No 10 (2017) |
Articles |
Statins and the liver: a point of view from the cardiologist |
|
| Vol 20, No 5 (2018) |
Articles |
Asthma and cardiovascular disease |
(Rus)
|
| Vol 20, No 3 (2018) |
Articles |
Alcohol and lungs |
(Rus)
|
| Vol 20, No 1 (2018) |
Articles |
Statins and diabetes mellitus: cardiologist’s point of view |
(Rus)
|
| Vol 20, No 1 (2018) |
Articles |
Chronic obstructive pulmonary disease and comorbid cardiovascular disease: in the context of guidelines |
(Rus)
|
| Vol 20, No 12 (2018) |
Articles |
Anxiety and depressive disorders in cardiology practice. Possibilities of using D,L-Hopantenic acid |
(Rus)
|
| Vol 20, No 12 (2018) |
Articles |
Antihypertensive therapy in patients with diabetes mellitus and chronic kidney disease specifications: the perspective of modern European guidelines 2018 |
(Rus)
|
| Vol 22, No 1 (2020) |
Articles |
OPTIMIZATION OF PHARMACOTHERAPY IN A POLYMORBID PATIENT WITH A COMBINATION OF CHRONIC HEART FAILURE AND CHRONIC KIDNEY DISEASE. CLINICAL CASE |
(Rus)
|
| Vol 21, No 12 (2019) |
Articles |
COMBINATION OF COMPONENTS FOR SUSTENANCE OR IMPROVEMENT OF ELDERLY AND SENIOR AGE PATIENTS’ FUNCTIONAL STATUS (ANTI-AGE MEDICINE) |
(Rus)
|
| Vol 21, No 10 (2019) |
Articles |
THE EFFECT OF INDIVIDUAL GROUPS OF DRUGS ON THE RISK OF PROLONGATION OF THE QTC INTERVAL |
(Rus)
|
| Vol 22, No 5 (2020) |
Articles |
How to improve anticoagulant therapy in atrial fibrillation? |
(Rus)
|
| Vol 21, No 12 (2019) |
Articles |
2018 AND 2019 GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION: IS THERE A PLACE FOR UNFIXED DRUG COMBINATIONS? |
(Rus)
|
| Vol 21, No 9 (2019) |
Articles |
DRUG-INDUCED DIZZINESS |
(Rus)
|
| Vol 22, No 5 (2020) |
Articles |
Impact of different medication groups on drug-induced seizures risk |
(Rus)
|
| Vol 23, No 6 (2021) |
Articles |
10 years of ARISTOTLE trial: results and lessons |
(Rus)
|
| Vol 23, No 10 (2021) |
Articles |
Interaction of drugs and coffee |
(Rus)
|
| Vol 21, No 5 (2019) |
Articles |
The clinical implication of the target organ protective properties of antihypertensive drugs in new guidelines for the management of arterial hypertension: the benefit of calcium channel blockers and diuretics |
(Rus)
|
| Vol 21, No 5 (2019) |
Articles |
Drug-induced long QT interval: prevalence, risk factors, treatment and prevention |
(Rus)
|
| Vol 21, No 4 (2019) |
Articles |
Medically induced hypoglycemia: focus on medications not included in the group of antihyperglycemic medications |
(Rus)
|
| Vol 21, No 1 (2019) |
Articles |
The new 2018 European guidelines for the management of arterial hypertension: the most important aspects of use in real-life clinical practice |
(Rus)
|
| Vol 21, No 2 (2019) |
Articles |
Influence of proton pump inhibitors on cognitive function and dementia risk |
(Rus)
|
| Vol 21, No 1 (2019) |
Articles |
Combined therapy with proton pump inhibitors and clopidogrel - focus on cardiovascular risk |
(Rus)
|
| Vol 23, No 12 (2021) |
Articles |
Hepatic impairment as a risk factor of adverse drug reactions |
(Rus)
|
| Vol 24, No 6 (2022) |
Articles |
Cancer treatment and drug-induced QT interval prolongation: A review |
(Rus)
|
| Vol 25, No 5 (2023): Gastroenterology |
Articles |
Gastroprotective therapy in patients with atrial fibrillation receiving anticoagulant therapy: A review |
(Rus)
|
